Pro-Dex Inc. (PDEX)

Name: Pro-Dex Inc. (PDEX) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Pro-Dex Inc. (PDEX)

Stock Card

$64.86

$1.02 (1.60%)

As on 27-Aug-2026 16:00EDT

Market cap

$210 Mln

Revenue (TTM)

$75 Mln

P/E Ratio

18.4

P/B Ratio

4.7

Div. Yield

0 %

Pro-Dex (PDEX) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 63.93 High: 66.36

52 Week Range

Low: 23.47 High: 69.86

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

0.3 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

12.2
Debt to Equity

0.3
Book Value

$--
EPS

$3.6
Face value

--
Shares outstanding

3,192,759

10 Years Aggregate

CFO

$17.45 Mln

EBITDA

$41.04 Mln

Net Profit

$33.03 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Pro-Dex (PDEX)	68.6	18.1	-0.4	38.9	59.1	16.2	28.4
BSE Sensex^*	-8.7	0.6	1.9	-4.3	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 27-Aug-2026 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Pro-Dex (PDEX)	-17.7	164.7	10.2	-31.5	-25.1	76.5	45.3
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Pro-Dex (PDEX)	64.9	209.7	74.6	12.0	23.2	27.7	18.4	4.7
10X Genomics Inc (TXG)	64.9	8,484.6	616.9	-75.1	1.7	-9.3	--	10.1
Avantor (AVTR)	14.6	9,638.1	6,561.1	-578.0	-4.5	-10.3	--	1.7
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.3
Bruker (BRKR)	59.3	9,074.5	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	181.9	10,905.5	612.8	-188.1	-30.6	-28.1	--	16.4
Lantheus Holdings (LNTH)	100.5	6,525.3	1,556.3	275.3	24.6	22.9	24	5.0
Merit Medical Systems (MMSI)	89.5	5,420.5	1,579.2	145.6	14.3	8.9	37.2	3.2
Penumbra (PEN)	321.0	12,752.7	1,504.9	160.6	13.6	10.9	79.4	8.4
Repligen (RGEN)	182.0	10,222.2	785.1	41.5	9.9	2	251.6	4.8

Shareholding Pattern

View Details

About Pro-Dex (PDEX)

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers... that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California. Read more

CEO, President, COO & Director

Mr. Richard Lee Van Kirk Jr.
CEO, President, COO & Director

Mr. Richard Lee Van Kirk Jr.
Headquarters

Irvine, CA
Website

https://www.pro-dex.com

FAQs for Pro-Dex (PDEX)

What is the current share price of Pro-Dex Inc (PDEX) Today?

The share price of Pro-Dex Inc (PDEX) is $64.86 (NASDAQ) as of 27-Aug-2026 16:00 EDT. Pro-Dex Inc (PDEX) has given a return of 59.08% in the last 3 years.

What is the current PB & PE ratio of Pro-Dex Inc (PDEX)?

The P/E ratio of Pro-Dex Inc (PDEX) is 18.40 times as on 21-Aug-2026, a 59 discount to its peers’ median range of 44.46 times.
The P/B ratio of Pro-Dex Inc (PDEX) is 4.73 times as on 21-Aug-2026, a 23 premium to its peers’ median range of 3.84 times.

PE & PB ratio at the end of financial year.